Pet Kidney Disease Treatment Market
PUBLISHED: 2026 ID: SMRC40474
SHARE
SHARE

Pet Kidney Disease Treatment Market

Pet Kidney Disease Treatment Market Forecasts to 2034 - Global Analysis By Disease Stage (Early-Stage Chronic Kidney Disease, Moderate Chronic Kidney Disease, Advanced Chronic Kidney Disease, Acute Kidney Injury), Treatment Type, Pet Type, Distribution Channel, and By Geography

4.7 (93 reviews)
4.7 (93 reviews)
Published: 2026 ID: SMRC40474

Due to ongoing shifts in global trade and tariffs, the market outlook will be refreshed before delivery, including updated forecasts and quantified impact analysis. Recommendations and Conclusions will also be revised to offer strategic guidance for navigating the evolving international landscape.
Loading...
According to Stratistics MRC, the Global Pet Kidney Disease Treatment Market is accounted for $1.9 billion in 2026 and is expected to reach $3.3 billion by 2034 growing at a CAGR of 7.1% during the forecast period. Pet kidney disease treatment encompasses therapeutic diets, pharmaceuticals, fluid therapy, supportive care, and diagnostic and monitoring solutions used to manage kidney disorders in companion animals. The market covers early-stage, moderate, and advanced chronic kidney disease, along with acute kidney injury. Cats represent a major patient population, while dogs and other companion animals also require veterinary renal care. Treatment approaches focus on slowing disease progression, managing complications, maintaining hydration and nutritional status, and improving quality of life. Increasing awareness of companion animal health, advances in veterinary diagnostics, and the availability of specialized renal nutrition and pharmaceutical therapies are supporting market development.

Market Dynamics:

Driver:

Increasing prevalence of chronic kidney disease in aging companion animals

The growing incidence and diagnosis of kidney disorders in companion animals, particularly older cats and dogs, are driving demand for veterinary renal care. Chronic kidney disease can progress gradually, making routine veterinary examinations and diagnostic testing important for identifying affected animals and monitoring disease progression. As pet owners increasingly seek preventive healthcare and longer, healthier lives for their animals, demand for renal therapeutic diets, prescription medicines, fluid therapy, and ongoing monitoring is expanding. Veterinary awareness of biomarkers, blood chemistry testing, urinalysis, and disease staging also supports earlier intervention. These developments are strengthening demand for comprehensive kidney disease management across veterinary clinics, hospitals, and specialized animal healthcare providers.

Restraint:

High treatment costs and challenges associated with long-term disease management

The cost of diagnosing and managing pet kidney disease can limit access to treatment, particularly when animals require repeated laboratory tests, prescription diets, medication, fluid therapy, and frequent veterinary consultations. Chronic kidney disease often requires sustained monitoring and individualized care, creating an ongoing financial commitment for pet owners. Treatment adherence can also be challenging because some animals have reduced appetite, difficulty accepting therapeutic diets, or resistance to medication administration. Advanced disease may require additional supportive interventions and more frequent clinical assessment. These factors can lead to delayed diagnosis, inconsistent treatment, or reduced use of comprehensive renal care, particularly in price-sensitive markets and regions with limited veterinary infrastructure.

Opportunity:

Advancements in early diagnostics and integrated renal treatment solutions

Developments in veterinary diagnostic biomarkers, point-of-care testing, therapeutic nutrition, and disease-specific medicines are creating opportunities for market expansion. Earlier identification of declining kidney function can help veterinarians initiate appropriate dietary and medical interventions and monitor disease progression more effectively. Diagnostic platforms that integrate renal biomarkers with routine chemistry testing can improve workflow efficiency and support wider screening. In addition, products that combine nutritional support with management of associated conditions may simplify treatment for pet owners and veterinary professionals. Digital veterinary records, teleconsultation services, and expanding access to specialized animal healthcare can further strengthen long-term monitoring. These advances are creating opportunities for diagnostic companies, pharmaceutical manufacturers, and veterinary nutrition providers.

Threat:

Regulatory requirements and variability in treatment outcomes

The pet kidney disease treatment market faces challenges associated with veterinary drug regulation, clinical evidence requirements, product safety, and the complexity of managing chronic disorders. Pharmaceutical products require appropriate authorization for their intended indications, while therapeutic diets must meet applicable nutritional and labeling requirements. Treatment outcomes can vary according to disease stage, underlying cause, concurrent conditions, and adherence to veterinary recommendations. Acute kidney injury may also require urgent intervention, with outcomes influenced by the severity of damage and the speed of treatment. Furthermore, differences in veterinary infrastructure and access to specialist diagnostics across countries can limit the adoption of advanced therapies. These factors increase the importance of clinical evidence, professional guidance, and reliable treatment protocols.

Covid-19 Impact:

The COVID-19 pandemic affected veterinary healthcare through temporary clinic restrictions, changes in appointment availability, supply chain disruptions, and shifts in pet owner spending. Some animals experienced delays in routine examinations and diagnostic procedures, while veterinary practices adapted through appointment management, teleconsultation, and other remote communication services where appropriate. At the same time, increased attention to companion animals and continued demand for essential veterinary products supported the resilience of animal healthcare. Following the pandemic, the importance of preventive examinations, routine laboratory testing, and sustained management of chronic conditions has reinforced demand for veterinary renal care. Market performance continues to reflect pet ownership trends, veterinary service accessibility, treatment affordability, and the availability of specialized products.

The Moderate Chronic Kidney Disease segment is expected to account for a significant share during the forecast period

The Moderate Chronic Kidney Disease segment is expected to represent a major share of the pet kidney disease treatment market because affected animals often require a combination of therapeutic nutrition, medication, monitoring, and supportive care. At this stage, management typically focuses on slowing disease progression, maintaining adequate food intake and hydration, and addressing complications such as hypertension, proteinuria, and mineral imbalances where present. Regular blood and urine testing helps veterinarians assess kidney function and adjust treatment plans. The need for ongoing management can generate sustained demand for prescription renal diets, pharmaceutical products, and diagnostic services. Increasing recognition of chronic kidney disease in aging cats and dogs further supports demand for treatment during moderate disease stages.

The Diagnostics and Monitoring segment is expected to witness strong growth during the forecast period

The Diagnostics and Monitoring segment is expected to experience strong growth as veterinary professionals increasingly emphasize early identification, disease staging, and ongoing assessment of kidney function. Blood chemistry testing, urinalysis, urine protein measurements, and renal biomarkers help veterinarians evaluate kidney health and identify changes that may not be apparent from clinical signs alone. Point-of-care diagnostic platforms and integrated laboratory systems can support more efficient testing during routine veterinary visits. Regular monitoring also helps guide dietary recommendations, medication adjustments, and the management of associated complications. As pet owners place greater emphasis on preventive healthcare and veterinary practices adopt more advanced diagnostic tools, demand for renal testing and monitoring solutions is expected to increase.

Region with largest share:

During the forecast period, North America is expected to hold the largest share of the Global Pet Kidney Disease Treatment Market, supported by established veterinary healthcare infrastructure, high expenditure on companion animal care, and broad availability of specialized therapeutic products. The United States represents a major market for veterinary pharmaceuticals, prescription renal diets, laboratory diagnostics, and veterinary hospital services. Established animal health companies and diagnostic providers contribute to product availability and clinical adoption. Routine veterinary examinations and growing awareness of age-related conditions also support the diagnosis and management of chronic kidney disease in cats and dogs. Canada contributes to regional demand through its established veterinary service network, while Mexico offers opportunities as access to specialized animal healthcare expands.

Region with highest CAGR:

Asia Pacific is expected to register the highest CAGR during the forecast period, driven by expanding companion animal ownership, improving access to veterinary services, and increasing awareness of preventive animal healthcare. Growth in urban pet ownership across China, India, Japan, South Korea, and Australia is creating opportunities for therapeutic nutrition, veterinary medicines, and diagnostic solutions. Investments in veterinary clinics, specialty hospitals, laboratory services, and digital pet healthcare platforms are improving access to disease management. The expansion of online channels for eligible pet healthcare products and the growing availability of specialized veterinary diets are also supporting market development. Rising interest in companion animal longevity and professional veterinary care is expected to strengthen demand for renal disease treatment across the region.

Key players in the market

Some of the key players in the Global Pet Kidney Disease Treatment Market include Hill's Pet Nutrition, Inc., Royal Canin, Nestlé Purina PetCare, Dechra Pharmaceuticals PLC, Boehringer Ingelheim, Elanco Animal Health Incorporated, Virbac, IDEXX Laboratories, Inc., Antech Diagnostics, Inc., and Baxter International Inc.

Key Developments:

In June 2026, Hill's Pet Nutrition introduced Prescription Diet k/d + Derm Complete for dogs and Prescription Diet k/d + z/d Hydrolyzed for cats. These veterinary-recommended therapeutic diets are designed to support kidney function in pets with concurrent skin or gastrointestinal sensitivities, expanding nutritional options for animals with multiple health needs.

In May 2026, IDEXX Laboratories announced that its SDMA renal biomarker would be integrated into commonly used Catalyst chemistry profiles in the United States and Canada. The integration expands access to kidney function assessment within routine point-of-care testing workflows and supports earlier evaluation of renal health in companion animals.

In November 2025, Virbac launched Vikaly, a medicated food for cats with chronic kidney disease that combines renal nutrition with benazepril to help manage proteinuria. The product integrates nutritional and pharmaceutical approaches into a single feeding solution, addressing treatment administration challenges in feline renal care.

In March 2025, Elanco Animal Health announced a research agreement to explore novel therapies for chronic kidney disease and life extension in pets. The initiative reflects continued research interest in developing new approaches to age-related conditions and improving long-term health outcomes in companion animals.

Disease Stages Covered:
• Early-Stage Chronic Kidney Disease
• Moderate Chronic Kidney Disease
• Advanced Chronic Kidney Disease
• Acute Kidney Injury

Treatment Types Covered:
• Renal Therapeutic Diets
• Pharmaceuticals
• Fluid and Supportive Therapy
• Diagnostics and Monitoring

Pet Types Covered:
• Cats
• Dogs
• Other Companion Animals

Distribution Channels Covered:
• Veterinary Clinics and Hospitals
• Veterinary Pharmacies
• Online Channels

Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa

What our report offers:
• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements

Free Customization Offerings:
All customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Pet Kidney Disease Treatment Market, By Disease Stage
5.1 Early-Stage Chronic Kidney Disease
5.2 Moderate Chronic Kidney Disease
5.3 Advanced Chronic Kidney Disease
5.4 Acute Kidney Injury

6 Global Pet Kidney Disease Treatment Market, By Treatment Type
6.1 Renal Therapeutic Diets
6.2 Pharmaceuticals
6.3 Fluid and Supportive Therapy
6.4 Diagnostics and Monitoring

7 Global Pet Kidney Disease Treatment Market, By Pet Type
7.1 Cats
7.2 Dogs
7.3 Other Companion Animals

8 Global Pet Kidney Disease Treatment Market, By Distribution Channel
8.1 Veterinary Clinics and Hospitals
8.2 Veterinary Pharmacies
8.3 Online Channels

9 Global Pet Kidney Disease Treatment Market, By Geography
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa

10 Strategic Market Intelligence
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives

12 Company Profiles
12.1 Hill's Pet Nutrition, Inc.
12.2 Royal Canin
12.3 Nestlé Purina PetCare
12.4 Dechra Pharmaceuticals PLC
12.5 Boehringer Ingelheim
12.6 Elanco Animal Health Incorporated
12.7 Virbac
12.8 IDEXX Laboratories, Inc.
12.9 Antech Diagnostics, Inc.
12.10 Baxter International Inc.

List of Tables
1 Global Pet Kidney Disease Treatment Market Outlook, By Region (2023–2034) ($MN)
2 Global Pet Kidney Disease Treatment Market Outlook, By Disease Stage (2023–2034) ($MN)
3 Global Pet Kidney Disease Treatment Market Outlook, By Early-Stage Chronic Kidney Disease (2023–2034) ($MN)
4 Global Pet Kidney Disease Treatment Market Outlook, By Moderate Chronic Kidney Disease (2023–2034) ($MN)
5 Global Pet Kidney Disease Treatment Market Outlook, By Advanced Chronic Kidney Disease (2023–2034) ($MN)
6 Global Pet Kidney Disease Treatment Market Outlook, By Acute Kidney Injury (2023–2034) ($MN)
7 Global Pet Kidney Disease Treatment Market Outlook, By Treatment Type (2023–2034) ($MN)
8 Global Pet Kidney Disease Treatment Market Outlook, By Renal Therapeutic Diets (2023–2034) ($MN)
9 Global Pet Kidney Disease Treatment Market Outlook, By Pharmaceuticals (2023–2034) ($MN)
10 Global Pet Kidney Disease Treatment Market Outlook, By Fluid and Supportive Therapy (2023–2034) ($MN)
11 Global Pet Kidney Disease Treatment Market Outlook, By Diagnostics and Monitoring (2023–2034) ($MN)
12 Global Pet Kidney Disease Treatment Market Outlook, By Pet Type (2023–2034) ($MN)
13 Global Pet Kidney Disease Treatment Market Outlook, By Cats (2023–2034) ($MN)
14 Global Pet Kidney Disease Treatment Market Outlook, By Dogs (2023–2034) ($MN)
15 Global Pet Kidney Disease Treatment Market Outlook, By Other Companion Animals (2023–2034) ($MN)
16 Global Pet Kidney Disease Treatment Market Outlook, By Distribution Channel (2023–2034) ($MN)
17 Global Pet Kidney Disease Treatment Market Outlook, By Veterinary Clinics and Hospitals (2023–2034) ($MN)
18 Global Pet Kidney Disease Treatment Market Outlook, By Veterinary Pharmacies (2023–2034) ($MN)
19 Global Pet Kidney Disease Treatment Market Outlook, By Online Channels (2023–2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We offer complimentary customization of up to 15% with every purchase.

To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .

Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials